Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by brad129on Mar 22, 2023 12:23pm
132 Views
Post# 35353898

Jboy/Rebecca

Jboy/Rebecca

Rebecca/ Jboy aren't going to like it didn't we just give GEM how many shares plus warrants at $.06 because based on this my recollection was wrong the deal was 15 million shares to Heatth Clinics at the time we're about 1.50 which valued Care at 22 million plus or minus. Then there were 8 million contingent on milestones that we give or pay $2 each so essentially another 16 million so Health clinics expectations was their deal would be 38 million or greater at the time. Today they would be worth $2,415,000 that's a substantial drop wouldn't you say Rebecca/jboy

now considering the milestones haven't been met this is still pretty darn relevant especially if I was sitting in Health Clinics seat. 

oh here is the cut from NR that Rebecca/Jboy don't want to talk about.
The letter of intent commits the HC Companies to negotiate exclusively with StageZero for one hundred and twenty (120) days, and is binding as to payment terms. The payment terms contemplate that StageZero will issue 15,000,000 common shares (the "Closing Consideration") to the vendors on the closing of the Transaction, with an additional 8,000,0000 common shares (the "Contingent Consideration") potentially issuable to the vendors post-closing, contingent upon the achievement of certain performance milestones.

<< Previous
Bullboard Posts
Next >>